GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Titan Biotech Ltd (BOM:524717) » Definitions » 5-Year ROIIC %

Titan Biotech (BOM:524717) 5-Year ROIIC % : 18.80% (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Titan Biotech 5-Year ROIIC %?

5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year. Titan Biotech's 5-Year ROIIC % for the quarter that ended in Mar. 2024 was 18.80%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Titan Biotech's 5-Year ROIIC % or its related term are showing as below:

BOM:524717's 5-Year ROIIC % is ranked better than
72.87% of 1301 companies
in the Biotechnology industry
Industry Median: -22.17 vs BOM:524717: 18.80

Titan Biotech 5-Year ROIIC % Historical Data

The historical data trend for Titan Biotech's 5-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Biotech 5-Year ROIIC % Chart

Titan Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
5-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.87 52.58 36.10 24.60 18.80

Titan Biotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
5-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 18.80 - -

Competitive Comparison of Titan Biotech's 5-Year ROIIC %

For the Biotechnology subindustry, Titan Biotech's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Titan Biotech's 5-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Titan Biotech's 5-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Titan Biotech's 5-Year ROIIC % falls into.



Titan Biotech 5-Year ROIIC % Calculation

Titan Biotech's 5-Year ROIIC % for the quarter that ended in Mar. 2024 is calculated as:

5-Year ROIIC %=5-Year Incremental Net Operating Profit After Taxes (NOPAT)**/5-Year Incremental Invested Capital**
=( 232.3120215 (Mar. 2024) - 52.1780466 (Mar. 2019) )/( 1543.401 (Mar. 2024) - 585.466 (Mar. 2019) )
=180.1339749/957.935
=18.80%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Titan Biotech  (BOM:524717) 5-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Titan Biotech 5-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Titan Biotech's 5-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Titan Biotech Business Description

Traded in Other Exchanges
N/A
Address
903-909, 9th Floor, Bigjos Tower, Netaji Subhash Place, Delhi, IND, 110034
Titan Biotech Ltd is a manufacturer and exporter of biological products. It manufactures biological products such as peptone, malt extract, yeast extract, liver extract, bile extract, culture media, laboratory chemicals, plant growth promoters and others. The biological products have applications in the field of pharmaceutical, nutraceutical, food and beverages, biotechnology and fermentation, cosmetic, veterinary and animal feed, agriculture industries, and others. The Company's business activity falls within a single primary business segment which is business of Biological Products. The firm sells its products in India and also exports internationally, of which the majority of the revenue is derived from the sales made in India.

Titan Biotech Headlines

No Headlines